Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes, a comparative cohort study suggests.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/gi-safety-similar-popular-weight-loss-drugs-2025a1000ub6?src=rss
Author :
Publish date : 2025-11-04 12:28:00
Copyright for syndicated content belongs to the linked Source.
